Weight loss implant could replace weekly shots
Symptom relief
Not yet recruiting
This early study tests a small implant placed under the skin that releases semaglutide (the drug in Wegovy) over 4 weeks. It compares the implant to weekly injections in 20 healthy overweight or obese adults. The goal is to see if the implant is safe and how it affects drug level…
Phase: PHASE1 • Sponsor: Vivani Medical, Inc • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC